Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.91 +0.01 (+0.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMAA) Net Income (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMAA) recorded Net Income of $1.73 million in Q2 2026, down 24.5% from $2.29 million a year earlier.

Analysis

Drugs Made In America Acquisition (DMAA) Net Income (2024 - 2026) Analysis & Trends

On a TTM basis, Drugs Made In America Acquisition's Net Income came in at $6.41 million as of Jun 30, 2026; for FY2025, it was $5.94 million.

  • Across earlier years, Net Income came in at -$279,845 in FY2024.
  • Quarterly Net Income has ranged from $212,958 in Q4 2025 to $2.29 million in Q2 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - 1.92 Bn
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -19.38 Bn
3 Brookfield 101.47 Bn -96.66 Bn - 1.91 Bn
4 Blackstone 91.35 Bn 85.56 Bn - 1.27 Bn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn 1.24 Bn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - 3.00 Bn
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn -1.12 Bn
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn 410.25 Mn
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn 85.33 Mn
10 Drugs Made In America Acquisition 336.16 Mn 336.12 Mn - 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.73 Mn
Mar 31, 2026 1.97 Mn
Dec 31, 2025 212,958.00
Sep 30, 2025 2.18 Mn
Jun 30, 2025 2.29 Mn
Mar 31, 2025 1.25 Mn
Dec 31, 2024 -79,986.00
Sep 30, 2024 -144,928.00
API Access

Drugs Made In America Acquisition Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=DMAA&period=max&api_key=YOUR_API_KEY